OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 122 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $65,000 | -66.7% | 115,435 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $195,000 | -2.5% | 113,660 | +19.9% | 0.00% | 0.0% |
| Q3 2015 | $200,000 | -57.8% | 94,805 | -1.0% | 0.00% | -50.0% |
| Q2 2015 | $474,000 | -50.6% | 95,776 | -21.9% | 0.00% | -33.3% |
| Q1 2015 | $960,000 | +55.3% | 122,636 | +20.3% | 0.00% | +50.0% |
| Q4 2014 | $618,000 | +50.4% | 101,911 | +5.7% | 0.00% | +100.0% |
| Q3 2014 | $411,000 | -33.7% | 96,436 | -3.9% | 0.00% | -50.0% |
| Q2 2014 | $620,000 | +9.5% | 100,391 | +15.2% | 0.00% | 0.0% |
| Q1 2014 | $566,000 | +15.5% | 87,127 | +0.0% | 0.00% | +100.0% |
| Q4 2013 | $490,000 | -10.1% | 87,087 | -1.8% | 0.00% | -50.0% |
| Q3 2013 | $545,000 | +6.9% | 88,707 | +1.8% | 0.00% | 0.0% |
| Q2 2013 | $510,000 | – | 87,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |